Perinatal Mood and Anxiety Disorder Screening During Fertility Treatment: Timing, Instruments, and Pre-OB Transfer Handoff

Fertility patients arrive in OB care carrying psychiatric risk factors that the receiving provider rarely knows about. The fertility clinic has the clinical context, the treatment history, and the opportunity to screen, but most clinics lack a structured protocol for doing so. The result: a high-risk population transfers into prenatal care without a single documented mental health data point. This guide covers when to screen during fertility treatment, which instruments to use at each stage, and how to structure a handoff note that gives the OB what they need.

Why Fertility Patients Warrant Targeted PMAD Screening

Infertility grief, repeated cycle failures, hormonal fluctuation from controlled ovarian stimulation, and prior pregnancy loss each independently elevate PMAD risk. Together, they create a risk profile qualitatively different from the general obstetric population. Studies document clinically significant anxiety in 30 to 40 percent of women during IVF treatment (Volgsten et al., 2010, Acta Obstet Gynecol Scand). A meta-analysis in the Journal of Affective Disorders found that prior pregnancy loss significantly increases odds of depression and anxiety in subsequent pregnancies (Biaggi et al., 2016). Achieving pregnancy does not resolve accumulated distress. It shifts it.

ACOG Committee Opinion No. 757 recognizes psychosocial risk factors as appropriate targets for obstetric screening. ASRM's 2018 Ethics Committee opinion acknowledges the psychological burden of fertility treatment but stops short of mandating routine screening for all IVF/IUI patients. The gap between recognized risk and systematic screening practice is where most fertility clinics currently sit.

When to Screen: Three Clinical Inflection Points

Screening produces the most useful data when it coincides with clinical transitions. Three time points align with shifts in patient psychology and clinic workflow.

Before the First Retrieval or Transfer

Baseline screening captures pre-existing mood and anxiety disorders before fertility treatment compounds them. Patients with prior depression, generalized anxiety, or trauma-related conditions (particularly from prior pregnancy loss) are at substantially higher PMAD risk. Identifying them early allows the fertility team to offer concurrent mental health support rather than waiting for symptoms to escalate.

The PHQ-9 and GAD-7 are appropriate here. Both are validated in general adult populations and generate numeric scores that can be tracked longitudinally. The PCL-5 is warranted for patients with known pregnancy loss history, as post-traumatic stress in this population is underdiagnosed.

At Positive Beta-hCG Confirmation

Clinicians often misread the positive pregnancy test as a purely positive moment. For many fertility patients, confirmed pregnancy triggers a shift from treatment-focused anxiety to pregnancy-specific anxiety: fear of loss, hypervigilance about symptoms, difficulty trusting the pregnancy will continue. Patients who were psychologically stable during treatment sometimes decompensate here.

The GAD-7 and PHQ-9 at the beta confirmation visit take under five minutes. The EPDS becomes appropriate at this point and can replace or supplement the PHQ-9, since the patient is now in the perinatal window. A score of 10 or higher on the EPDS, GAD-7, or PHQ-9 warrants a documented flag and clinical follow-up.

At the Pre-OB Transfer Visit

This is the last opportunity to generate a documented mental health data point before the patient leaves fertility care. Whatever the clinic does not capture here will likely not be captured until the OB's standard screening window, which may be weeks or months later.

Screen with the EPDS and GAD-7 at the final fertility clinic visit. Document the scores. Include them in the transfer summary. This is the single highest-yield action a fertility clinic can take to close the handoff gap.

Choosing the Right Instrument at Each Stage

| Treatment stage | Recommended instruments | Rationale | |---|---|---| | Pre-retrieval/pre-transfer baseline | PHQ-9, GAD-7, PCL-5 (if loss history) | General adult norms apply; captures pre-existing conditions | | Positive beta-hCG | GAD-7, PHQ-9 or EPDS | Patient enters perinatal window; EPDS becomes applicable | | Pre-OB transfer visit | EPDS, GAD-7 | Generates scores for handoff documentation; EPDS aligns with OB screening continuity |

The EPDS has a sensitivity of approximately 80 percent and specificity of approximately 90 percent for major depression at a cutoff of 13 or higher. At a cutoff of 10, it captures probable minor depression and anxiety. The GAD-7 adds specificity for generalized anxiety that the EPDS may underdetect. Using both at the pre-transfer visit takes under ten minutes combined.

Clinics that prefer one depression instrument throughout treatment can use the PHQ-9 pre-pregnancy and transition to the EPDS once pregnancy is confirmed. Longitudinal score comparison requires using the same instrument across time points.

Structuring the Pre-OB Transfer Handoff Note

The standard fertility-to-OB transfer summary covers treatment history, medication, and early pregnancy labs. Mental health information is rarely included because no field in the standard template prompts for it. A one-paragraph addendum closes this gap without additional staffing or a formal psychiatric consultation. Include:

• Screening scores with dates: "GAD-7: 14 (2026-02-10, pre-transfer visit). EPDS: 11 (2026-02-10)."
• Prior pregnancy loss history: Number of losses, gestational ages, and whether any were traumatic (e.g., second-trimester loss, stillbirth).
• Mental health treatment history: Current or prior diagnoses, psychotropic medications, therapy engagement during fertility treatment.
• Engagement with mental health support: Whether the patient accepted or declined referrals during treatment.
• Number of treatment cycles: Six IVF cycles carries a meaningfully different psychological load than one IUI cycle, and the OB will not know the difference unless told.

For patients with EPDS scores of 13 or higher, active psychiatric medication, or a history of prior PMAD episodes, a warm handoff is more effective than a chart note alone. A brief phone call or secure message to the receiving OB ensures the information is received before the first prenatal visit.

Connecting Patients to Perinatal Mental Health Support at Transfer

Fertility patients with elevated screening scores or known psychiatric history benefit from a mental health referral that is initiated before the OB transition, not deferred to the OB to arrange. The fertility team can submit a referral to Phoenix Health at the time of the pre-transfer visit; the response window is one business day, and care coordination begins before the patient's first OB appointment.

Phoenix Health's therapists hold PMH-C certification from Postpartum Support International and work with patients whose perinatal mental health conditions developed in the context of fertility treatment, pregnancy loss, and assisted reproduction. Telehealth delivery means the patient can begin sessions during the transition period rather than waiting for the OB to generate a separate referral weeks later.

Interested in building a structured referral pathway between your fertility clinic and perinatal mental health support? Reach out to discuss collaborative care options.